Rion stock has been grinding lower in recent weeks, with the price at ¥3,330 and down over the past month, yet the latest quarter tells a more nuanced story. The immediate headline is earnings pressure. Q1 2027 basic earnings per share came in at ¥55.72 on revenue of ¥6,885m, softer than the prior quarter. This keeps the focus firmly on profit resilience in a medical equipment business that trades on its ability to convert steady sales into reliable margins over time.
Love the steady revenue base at Rion but concerned about earnings pressure and margin resilience? Check out our screener of list of solid balance sheet and fundamentals stocks (37 results).
Q1 2027 Earnings Summary
- Revenue, Q1 2027 vs. Q1 2026: ¥6,885m vs. ¥6,629.1m…
